Robuta

https://pharmaceuticaldaily.com/pharmakon-bets-again-this-time-the-odds-are-harder-to-read/ Pharmakon bets again, this time the odds are harder to read – pharmaceutical daily BioPharma Credit deploys another $125 million into a pre-approval biotech. But the company it just backed is the one whose stock fell more than 50% on its... harder to readthis timethe odds